What is the Return on Assets (ROA) of Collplant Biotechnologies this year?
The Return on Assets (ROA) of Collplant Biotechnologies is -0.21 undefined this year.
Collplant Biotechnologies ROA 2024
Collplant Biotechnologies ROA
-0.21
Collplant Biotechnologies Dividend yield
Ticker
CLGN
ISIN
US19516R1077
WKN
A2PMPX
In 2024, Collplant Biotechnologies's return on assets (ROA) was -0.21, a -54.11% increase from the -0.45 ROA in the previous year.
Collplant Biotechnologies Aktienanalyse
What does Collplant Biotechnologies do?
CollPlant Biotechnologies Ltd is a biotechnology company specializing in the development and production of collagen-based products. The company was founded in 2004 and is headquartered in Rehovot, Israel. The company's history is rooted in collagen research. Collagen is an important component of connective tissue, providing structure and strength. The company specializes in the use of plant-based collagen derived from a specific plant called Nicotiana tabacum. Plant-based collagen has the advantage of being biocompatible, biodegradable, and more cost-effective than animal-based collagen. CollPlant Biotechnologies' business model is to develop and sell collagen-based products for various industries. The company's main sectors are medicine, cosmetics, and 3D printing. Each sector offers its own products and has different requirements for collagen. In the medicine sector, CollPlant Biotechnologies offers collagen-based products for wound healing, bone regeneration, and treatment of skin diseases. The advantage of plant-based collagen is that it causes very few allergic reactions and is well tolerated. In the cosmetics sector, the company develops collagen-based products for skincare, particularly for reducing wrinkles and fine lines. CollPlant Biotechnologies also has its own cosmetics brand called "Verifeel," which offers collagen-based creams and serums. The 3D printing sector is a relatively new initiative for the company. Here, CollPlant Biotechnologies develops collagen-based materials that can be used for 3D printing of biological tissues and organs. The advantage of plant-based collagen in 3D printing is that it is highly moldable and biocompatible. CollPlant Biotechnologies also has a partnership with one of the world's largest tobacco companies, Philip Morris International. Together, they are working to produce plant-based collagen on an industrial scale. Overall, CollPlant Biotechnologies has a promising future. The company has specialized in a unique niche in the biotechnology sector and offers a variety of products for different industries. With the partnership with Philip Morris International and the development of 3D printing materials, the company also has other exciting opportunities for the future. Collplant Biotechnologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Collplant Biotechnologies's Return on Assets (ROA)
Collplant Biotechnologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Collplant Biotechnologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Collplant Biotechnologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Collplant Biotechnologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Collplant Biotechnologies Stock
What was the ROA of Collplant Biotechnologies compared to the previous year?
The ROA of Collplant Biotechnologies has increased by -54.11% compared to the previous year.
What consequences do high ROA have for investors of Collplant Biotechnologies?
A high ROA is advantageous for investors of Collplant Biotechnologies, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Collplant Biotechnologies?
A low ROA can be unfavorable for investors of Collplant Biotechnologies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Collplant Biotechnologies affect the company?
An increase in ROA of Collplant Biotechnologies can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Collplant Biotechnologies impact the company?
A reduction in the ROA of Collplant Biotechnologies can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Collplant Biotechnologies?
Some factors that can influence the ROA of Collplant Biotechnologies include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Collplant Biotechnologies important for investors?
The ROA of Collplant Biotechnologies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Collplant Biotechnologies take to improve ROA?
To improve ROA, Collplant Biotechnologies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Collplant Biotechnologies pay?
Over the past 12 months, Collplant Biotechnologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collplant Biotechnologies is expected to pay a dividend of 0 USD.
What is the dividend yield of Collplant Biotechnologies?
The current dividend yield of Collplant Biotechnologies is .
When does Collplant Biotechnologies pay dividends?
Collplant Biotechnologies pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Collplant Biotechnologies?
Collplant Biotechnologies paid dividends every year for the past 0 years.
What is the dividend of Collplant Biotechnologies?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Collplant Biotechnologies located?
Collplant Biotechnologies is assigned to the 'Health' sector.
Wann musste ich die Aktien von Collplant Biotechnologies kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Collplant Biotechnologies from 6/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/9/2024.
When did Collplant Biotechnologies pay the last dividend?
The last dividend was paid out on 6/9/2024.
What was the dividend of Collplant Biotechnologies in the year 2023?
In the year 2023, Collplant Biotechnologies distributed 0 USD as dividends.
In which currency does Collplant Biotechnologies pay out the dividend?
The dividends of Collplant Biotechnologies are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Collplant Biotechnologies
Our stock analysis for Collplant Biotechnologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collplant Biotechnologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Collplant Biotechnologies Revenue
- Collplant Biotechnologies Net Income
- Collplant Biotechnologies P/E
- Collplant Biotechnologies P/S
- Collplant Biotechnologies EBIT
- Collplant Biotechnologies Dividend
- Collplant Biotechnologies Stocks
- Collplant Biotechnologies Market capitalization
- Collplant Biotechnologies Debt
- Collplant Biotechnologies Liabilities
- Collplant Biotechnologies Equity
- Collplant Biotechnologies AAQS
- Collplant Biotechnologies Employees
- Collplant Biotechnologies ROE
- Collplant Biotechnologies ROA
- Collplant Biotechnologies ROCE
